About Us
Radically outpacing traditional BCI.
Our mission is to create an endovascular implant that can transfer information from every corner of the brain at scale.
Our story
Innovating an Industry
Since 2012, we have been developing a solution that avoids the need for open brain surgery by using a minimally-invasive procedure.
Quick facts about us
01
The device, the stentrode™, is 8mm in diameter and made from a flexible alloy called nitinol. It is inserted into Superior Sagittal Sinus in the brain via the jugular vein.
02
Initial grant funding was provided to a lab in the University of Melbourne by the U.S. Defense Advanced Research Projects Agency (DARPA) and Department of Defense (DoD).
03
In 2020, FDA awarded the stentrode™ the Breakthrough Device Designation. In 2021, Synchron became the first company to receive an FDA IDE to conduct trials of a permanently implantable BCI.
04
Series B funding was led by Khosla Ventures, with total capital raised now of $70M, including support from the U.S. and Australian governments.
05
Synchron is headquartered in Brooklyn, New York, and has an office in Melbourne, Australia.
Leadership Team
We’re a global team of scientists, innovators, and future-thinkers.
Tom Oxley
CEO
Martin Dieck
Chairman of the Board
Nick Opie
CIO
J Mocco
Chief Medical Officer
Kurt Haggstrom
Chief Commercial Officer
Amos Meltzer
Chief Legal Officer
Connie Rey
VP, Clinical Affairs
Riki Banerjee
VP, R&D
Gary Castro
VP, Finance
Peter Yoo
Senior Director, Neuroscience
Gil Rind
Senior Director, Advanced Tech
Rina Bhagat
Senior Director, Quality & Regulatory
Darragh McDermott
Director, Hardware
Chloe Brown
Director, Strategic Marketing
Kimberly Ha
Communications Lead
Awards
Partners
Board
Advisors
Bloomberg 50
Bloomberg
2022
The Best Inventions of 2021
Time Magazine
2021
Next Big Things in Tech
Fast Company
2021
Most Disruptive Innovator Award
Newsweek
2021
Innovation Award
Society of Vascular and Neurointerventional Neurology
2021
BCI Award
BCI Award Foundation
2021
Innovator of the Year Finalist
Gentlemen’s Quarterly
2019
Advance Global Overall Australian of the Year
Advance Awards
2019
UNSW Eureka Prize for Excellence in Interdisciplinary Scientific Research
Australian Museum
2019
Innovator of the Year Finalist
Congress of Neurological Surgeons
2018
Khosla Ventures
Neuro Technology Investors
Metis Innovative
Martin Dieck, Chairman
Managing Member, Neuro Technology Investors
Tom Oxley
CEO, Synchron
Nick Opie
CTO, Synchron
Rahul P Sharma, MD
Director Cath Lab, Interventional Cardiology, Stanford
Alex Morgan, MD, PhD
Partner, Khosla Ventures
Ari Nowacek, MD, PhD
Principal, ARCH Venture Partners
Eddie Chang, MD
Chair, Dept of Neurosurgery UCSF
Tim Denison, PhD
Royal Academy Chair, Oxford University
Jordi Parramon, PhD
President, Google Verily
Earl Slee
VP, Medtronic (retired)
Victor Rodrigues
VP, Cochlear
Marc Slutzky, MD, PhD
Professor, Northwestern University
Josh Duyan
Investor, Artisan Partners
Max Hodak
CEO, Science (previously President at Neuralink)